Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, July 23, 2014 10:11:16 AM
bullish
## source: finance.yahoo.com
Tue, 22 Jul 2014 21:44:09 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In Vertex Pharmaceuticals Incorporated To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit -- VRTX
[GlobeNewswire] - STEVENSON, Md. -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District ...
read full: http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-214409376.html
*********************************************************
Fri, 18 Jul 2014 15:34:00 GMT ~ Sales Tax Compliance Concerns Loom Large, But Does Automation Help?
[at Forbes] - Many businesses may think they have taken the appropriate steps to be prepared for a sales and use tax audit, until the notice of audit arrives.
read full: http://www.forbes.com/sites/taxanalysts/2014/07/18/sales-tax-compliance-concerns-loom-large-but-does-automation-help/?partner=yahootix
*********************************************************
Thu, 17 Jul 2014 13:22:59 GMT ~ [$$] Costly Vertex Drug Is Denied, and Medicaid Patients Sue
[at The Wall Street Journal] - Vertex Pharmaceuticals' $300,000-a-year cystic-fibrosis drug has sparked a battle in Arkansas, illustrating the dilemma faced by cash-strapped government insurance programs.
read full: http://online.wsj.com/articles/costly-drug-vertex-is-denied-and-medicaid-patients-sue-1405564205?ru=yahoo?mod=yahoo_itp
*********************************************************
Wed, 16 Jul 2014 12:49:41 GMT ~ Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data
read full: http://finance.yahoo.com/news/biotech-stock-roundup-abbvie-woos-124941477.html
*********************************************************
Tue, 15 Jul 2014 17:32:26 GMT ~ SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX
[GlobeNewswire] - NEW YORK -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals ...
read full: http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-173226066.html
*********************************************************
$VRTX charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VRTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VRTX/company-info
Ticker: $VRTX
OTC Market Place: Not Available
CIK code: 0000875320
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
Incorporated In: MA, USA
$VRTX share structure
## source: otcmarkets.com
Market Value: $23,085,634,498 a/o Jul 22, 2014
Shares Outstanding: 236,194,337 a/o Apr 25, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$VRTX extra dd links
Company name: Vertex Pharmaceuticals Inc.
Company website: http://www.vpharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VRTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VRTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VRTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/news - http://finance.yahoo.com/q/h?s=VRTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VRTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VRTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VRTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Vertex+Pharmaceuticals+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Vertex+Pharmaceuticals+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Vertex+Pharmaceuticals+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.vpharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.vpharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.vpharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VRTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000875320&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VRTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VRTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VRTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VRTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VRTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VRTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VRTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VRTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VRTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VRTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VRTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VRTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VRTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VRTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VRTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VRTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VRTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VRTX
$VRTX DD Notes ~ http://www.ddnotesmaker.com/VRTX
jkflb
Recent VRTX News
- Santé Canada accorde l'autorisation de mise sur le marché de la première thérapie d'édition génomique CRISPR/Cas9, CASGEVY® (exagamglogène autotemcel), pour le traitement de l'anémie falciforme et de la bêta-thalassémie dépendante des transfusi • PR Newswire (Canada) • 09/25/2024 07:51:00 PM
- Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia • PR Newswire (Canada) • 09/25/2024 07:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:13:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:12:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:47:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:23:37 PM
- Vertex to Participate in Upcoming September Investor Conferences • Business Wire • 08/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:04:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:06:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2024 03:47:17 PM
- Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England • Business Wire • 08/07/2024 11:12:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 01:52:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:10:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2024 08:03:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:17:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:05:43 PM
- Vertex Reports Second Quarter 2024 Financial Results • Business Wire • 08/01/2024 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 07:34:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 07:25:57 PM
- Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain • Business Wire • 07/30/2024 05:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2024 08:06:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:05:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/24/2024 04:27:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 05:16:16 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM